HYALURONAN INDUCED TARGETING
USPTO Trademark Record · Serial No. 74593429
Trademark details
It was initially claimed by HYAL PHARMACEUTICAL CORPORATION on 19941101.
That brand applies to the following goods and services:pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elminiation of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; deto, acquisition, development and licensing of intellectual property technology regarding pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable and intravenous treatment of medical conditions and disease in humans.
Currently that trademark is represented by trademark attorney(s): IVOR M. HUGHES.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the HYALURONAN INDUCED TARGETING trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
